Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Matthew S.D. Kerr"'
Publikováno v:
The American Journal of Managed Care. 27:e372-e377
OBJECTIVES We evaluated the effects of acquiring a flash continuous glucose monitoring (CGM) system in the population with type 2 diabetes (T2D) treated with basal or noninsulin therapy. STUDY DESIGN This was a retrospective database analysis of the
Autor:
Sreekanth Vemulapalli, Matthew S.D. Kerr, Gregory J. Roberts, Julie B. Prillinger, Christopher U. Meduri, Patrick McCarthy
Publikováno v:
American heart journal. 245
Tricuspid valve disease (TVD) is presumed common, however, little is known about its prevalence or the impact of tricuspid valve surgery (TVS) on healthcare resource use.To describe the prevalence of TVD and assess the impact of TVS on resource utili
Autor:
Matthew S.D. Kerr, Irl B. Hirsch, Diana Souto, Richard M. Bergenstal, Yelena Nabutovsky, Gregory J. Roberts
Publikováno v:
Journal of the Endocrine Society
Purpose Suboptimal glycemic control among individuals with diabetes is a leading cause of hospitalizations and emergency department utilization. Use of flash continuous glucose monitoring (flash CGM) improves glycemic control in type 1 and type 2 dia
Autor:
Gregory J. Roberts, Matthew S.D. Kerr, Eugene Wright, Yelena Nabutovsky, Eden Miller, Diana Souto
Publikováno v:
Diabetes. 69
Data on the benefit of continuous glucose monitors (CGM) in people with diabetes not using intensive insulin therapy is limited. We describe clinical outcomes after a FreeStyle Libre® system purchase in people with type 2 diabetes (T2D) not using bo
Autor:
Richard M. Bergenstal, Matthew S.D. Kerr, Irl B. Hirsch, Yelena Nabutovsky, Gregory J. Roberts, Diana Souto
Publikováno v:
Diabetes. 69
Continuous glucose monitors (CGMs) improve glycemic control compared with self-monitoring of blood glucose. We aim to describe clinical outcomes in people with type 2 diabetes (T2D) who received FreeStyle Libre® system. IBM MarketScan™ Commercial
Publikováno v:
Diabetes. 69
Continuous glucose monitoring (CGM) in patients with diabetes using intensive insulin therapy has been well established, but there are limited data for CGM in other diabetes populations. We assessed HbA1c changes following a FreeStyle Libre prescript